Cargando…
Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
CONTEXT: Noncompliance with thyroxine therapy is the most common cause of poor control of hypothyroidism. An open-label prospective study to compare once-weekly thyroxine (OWT) with standard daily thyroxine (SDT) was undertaken. DESIGN: Patients taking thyroxine doses of >3 μg/kg/d, with or witho...
Autores principales: | Jayakumari, Chellama, Nair, Abilash, Puthiyaveettil Khadar, Jabbar, Das, Darvin V, Prasad, Nandini, Jessy, S J, Gopi, Anjana, Guruprasad, Padmanabhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834071/ https://www.ncbi.nlm.nih.gov/pubmed/31723717 http://dx.doi.org/10.1210/js.2019-00212 |
Ejemplares similares
-
Efficacy and Safety of Once Weekly Thyroxine as Compared to Daily Thyroxine in Managing Primary Hypothyroidism: A Systematic Review and Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2021) -
Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis
por: Soumya, Sarayu, et al.
Publicado: (2021) -
Slipped Capital Femoral Epiphysis in Primary Hyperparathyroidism - Case Report with Literature Review
por: George, Geena Susan, et al.
Publicado: (2019) -
Evaluation of the Optimal Thyroxine Levels for Thyroxine Hormone Replacement in Patients With Central Hypothyroidism
por: Lee, Ka Fai, et al.
Publicado: (2021) -
Prevalence of normoalbuminuric chronic kidney disease among individuals with type 2 diabetes mellitus from India
por: Jayakumari, Chellamma, et al.
Publicado: (2022)